CS
TPI

Credit Suisse’s TIANYIN PHARMACEUTICAL TPI Stock Holding History

Credit Suisse’s Portfolio TPI Stock Details TPI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-15,343
Closed -$15K – 4931
2014
Q1 		$15K Buy
+15,343
New +$15.4K ﹤0.01% 4621

Other funds holding TPI

PAM
Pope Asset Management Memphis, Tennessee $162M AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
RIM
Regent Investment Management Louisville, Kentucky $373M AUM 10.22% 1-Year Est. Return
SIM
Spark Investment Management New York $41.6M AUM 80.97% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
BWFA
Baltimore-Washington Financial Advisors Columbia, Maryland $2.32B AUM 16.8% 1-Year Est. Return

Credit Suisse's TPI Position: Q2 2014 in Review

Credit Suisse sold out of TIANYIN PHARMACEUTICAL (TPI) in Q2 2014, closing a stake of 15,343 shares — an estimated $15K sold.

Credit Suisse first reported a position in TPI in Q1 2014 and held it in 1 quarter. The position peaked at $15K in Q1 2014. 6 funds tracked by Wall St. Rank hold TPI as of Q2 2014.

  • Credit Suisse reported no remaining TIANYIN PHARMACEUTICAL position as of Q2 2014 after selling out during the quarter.
  • Credit Suisse sold 15,343 TIANYIN PHARMACEUTICAL shares in Q2 2014, an estimated $15K.
  • Credit Suisse first reported a position in TIANYIN PHARMACEUTICAL in Q1 2014 and held it in 1 quarter.
  • Credit Suisse's TIANYIN PHARMACEUTICAL position peaked at $15K in Q1 2014.
  • 6 funds tracked by Wall St. Rank held TIANYIN PHARMACEUTICAL as of Q2 2014.

Based on Credit Suisse's 13F filing for Q2 2014, filed 11 Aug 2014.